Abstract Background Intention-to-treat (ITT) is the standard data analysis method which includes all patients regardless of receiving treatment. Although the aim of ITT analysis is to prevent bias due to prognostic dissimilarity, it is also a counter-intuitive type of analysis as it counts patients who did not receive treatment, and may lead to "bias toward the null." As treated (AT) method analyzes patients according to the treatment actually received rather than intended, but is affected by the selection bias. Both ITT and AT analyses can produce biased estimates of treatment effect, so instrumental variable (IV) analysis has been proposed as a technique to control for bias when using AT data. Our objective is to correct for bias in non-e...
Clinicians, institutions, and policy makers use results from randomized controlled trials to makedec...
The effects of immunosuppressive regimens on the outcomes of patients with hematological malignancie...
Background & Aim: Randomized controlled trials often suffer from two major problems, i.e., noncompli...
Patients in some randomized controlled trials (RCTs) may switch from the treatment arm to which they...
Patients in some randomized controlled trials (RCTs) may switch from the treatment arm to which they...
It may not always be possible to blind participants of a randomized controlled trial for treatment a...
It may not always be possible to blind participants of a randomized controlled trial for treatment a...
Background & Objectives: In clinical trials some of participants do not take assignment treatment. I...
Randomized controlled trials often suffer from two major complications, i.e., noncompliance and miss...
OBJECTIVE: Instrumental variable (IV) analysis may offer a useful approach to the problem of unmeasu...
Observational studies almost always have bias because prognostic factors are unequally distributed b...
Abstract Background Intention-to-treat (ITT) analysis is commonly recommended for use, due to its be...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Background: In the absence of randomized clinical trials, meta-analysis of individual patient data (...
A relevant problem in meta-analysis concerns the possible heterogeneity between trial results. If a ...
Clinicians, institutions, and policy makers use results from randomized controlled trials to makedec...
The effects of immunosuppressive regimens on the outcomes of patients with hematological malignancie...
Background & Aim: Randomized controlled trials often suffer from two major problems, i.e., noncompli...
Patients in some randomized controlled trials (RCTs) may switch from the treatment arm to which they...
Patients in some randomized controlled trials (RCTs) may switch from the treatment arm to which they...
It may not always be possible to blind participants of a randomized controlled trial for treatment a...
It may not always be possible to blind participants of a randomized controlled trial for treatment a...
Background & Objectives: In clinical trials some of participants do not take assignment treatment. I...
Randomized controlled trials often suffer from two major complications, i.e., noncompliance and miss...
OBJECTIVE: Instrumental variable (IV) analysis may offer a useful approach to the problem of unmeasu...
Observational studies almost always have bias because prognostic factors are unequally distributed b...
Abstract Background Intention-to-treat (ITT) analysis is commonly recommended for use, due to its be...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Background: In the absence of randomized clinical trials, meta-analysis of individual patient data (...
A relevant problem in meta-analysis concerns the possible heterogeneity between trial results. If a ...
Clinicians, institutions, and policy makers use results from randomized controlled trials to makedec...
The effects of immunosuppressive regimens on the outcomes of patients with hematological malignancie...
Background & Aim: Randomized controlled trials often suffer from two major problems, i.e., noncompli...